Skip to Main Content

Paper Details

Residual risk of transfusion-transmitted hepatitis B virus (TT-HBV) infection by NAT-screened blood components: A review of observed versus modeled infectivity from donors with window period and occult HBV infections.
Transfusion
6
2021
Author NameAffiliation
Michael P BuschVitalant Research Institute
Steven KleinmanUniversity of British Columbia
  • 1 - 2

Datasets

Release 1.2